Kaansla Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Panchkula, Haryana, India, established in 2020.
2020 Panchkula, Haryana, India Active
Last Updated:
Access Report
About Kaansla Pharmaceuticals Private Limited

Kaansla Pharmaceuticals Private Limited, a active private limited company, was established on 24 December 2020 in Panchkula, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239HR2020PTC091817. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.

Its leadership includes Satish Verma (Director), Monika Verma (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No. 698 Rai Pur Rani, Panchkula, Haryana, 134204.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239HR2020PTC091817

  • Registration Number

    091817

  • Incorporation Date

    24 December 2020

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 5 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 17.73%
  • Profit Growth **** 113.18%
  • Ebitda **** 107.90%
  • Net Worth 20.07%
  • Total Assets **** 19.34%
Company report

Kaansla Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kaansla Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kaansla Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Satish Verma Director 24 Dec 2020 Current
Monika Verma Director 24 Dec 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kaansla Pharmaceuticals.

Kaansla Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.73% increase. The company also saw a substantial improvement in profitability, with a 113.18% increase in profit. The company's net worth Soared by an impressive increase of 20.07%.

Kaansla Pharmaceuticals revenue growth over time
Kaansla Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.73%
*******
*******
*******
*******
Revenue from Operations
*******
 17.44%
*******
*******
*******
*******
Total Assets
*******
 19.34%
*******
*******
*******
*******
Profit or Loss
*******
 113.18%
*******
*******
*******
*******
Net Worth
*******
 20.07%
*******
*******
*******
*******
EBITDA
*******
 107.90%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kaansla Pharmaceuticals?

Unlock access to Kaansla Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kaansla Pharmaceuticals?

Kaansla Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kaansla Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaansla Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kaansla Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Kaansla Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Kaansla Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Satish Verma was appointed as a Director was appointed as a Director on 24 Dec 2020 & has been associated with this company since 5 years 1 month . was documented.

  • Director Appointment

    The activity Monika Verma was appointed as a Director was appointed as a Director on 24 Dec 2020 & has been associated with this company since 5 years 1 month . was completed.

  • Company Incorporation

    The activity Kaansla Pharmaceuticals Private Limited was registered on 24 Dec 2020 with Roc Delhi & aged 5 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kaansla Pharmaceuticals Private Limited?

The CIN of Kaansla Pharmaceuticals Private Limited is U24239HR2020PTC091817.

Where is Kaansla Pharmaceuticals Private Limited headquartered?

Kaansla Pharmaceuticals Private Limited is headquartered at House No. 698 Rai Pur Rani, Panchkula, Haryana, 134204.

When was Kaansla Pharmaceuticals Private Limited incorporated?

Kaansla Pharmaceuticals Private Limited was incorporated on 24 December 2020.

Who are the current directors of Kaansla Pharmaceuticals Private Limited?

The current directors of Kaansla Pharmaceuticals Private Limited are

What is the primary industry of Kaansla Pharmaceuticals Private Limited?

The primary industry of Kaansla Pharmaceuticals Private Limited is Trade.

Is Kaansla Pharmaceuticals Private Limited a listed company?

Kaansla Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kaansla Pharmaceuticals Private Limited?

The authorized capital of Kaansla Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available